Community Research and Development Information Service - CORDIS


ELECTOR Report Summary

Project ID: 643481
Funded under: H2020-EU.3.1.

Periodic Reporting for period 1 - ELECTOR (eHealth in Rheumatology)

Reporting period: 2015-01-01 to 2015-12-31

Summary of the context and overall objectives of the project

The overall purpose of the ELECTOR project is to deliver an integrated eHealth platform and bring forth a feasible and valuable clinical concept to patients across Europe.

The ELECTOR project will develop, test, implement, and evaluate an eHealth platform for home-based monitoring of patients with rheumatoid arthritis. The proposed platform will encompass a web-based software for communication and data transfer in combination with miniturized biochemistry devices using blood retrieved by finger pricking for measuring C-reactive protein (CRP), the liver biomarker alanine aminotransferase (ALT), granulocytes and haemoglobin at home. The end result is an eHealth platform that will provide an integrated and direct collection of data into patient notes in the set-up of an eHealth outpatient clinic for citizens with rheumatoid arthritis.

The adaptive and flexible nature of this solution will change the provision of health care and may be disseminated to monitor a variety of diseases.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

As of activities carried out and actual deliveries by end 2015, the device and assay partners have made 1) remarkable progress in terms of moving closer towards approvals of all the elements related to the PoC devices and with respect to preparing for production of assays, cartridges, and devices. The software partner has 2) developed and launched the 1st version of the ICT platform in two clinical sites, in the Czech Republic and Denmark. Even more, 3) preparations and progress have been undertaken for a full-scale launch of the ICT platform. The clinical partners have 4) launched clinical trial no. 1 and are engaged in the inclusion of patients for this trial aiming to explore the reliability of home-based monitoring via the eHealth platform and the agreement between monitoring data derived by patients and healthcare professionals (HCPs). In addition, the partners have been involved in 5) preparations for clinical trial no. 2; specifically in terms of medical imaging, reimbursement of outpatient clinical activities, guidance and information materials, and adaptation of the clinical organisational setup. User involvement and participatory design have been in focus during the first 12 months of the project. All partners have been involved in activities related to this, and 6) learnings from these participatory interactions, workshops, and interviews have been of huge importance, and based on this, 7) motivations, aspirations, needs, expectations, as well as socio-economic aspects relating to all relevant stakeholder groups in each of the participating countries have been mapped and a stakeholder management plan is in the process of being made. This work will continue, and is expected to impact the remaining part of the project. The project has 8) established itself on various platforms incl. a webpage, Facebook, Twitter, and LinkedIN. In addition, the project has been active in terms of connecting and coordinating the non-scientific communication from partners and overall project, and assisted in creating 9) awareness for the project and its partners on national and international media platforms. The management team has 10) initiated and co-developed a series of clinical trials concepts and assisted the partners in the advancement of business ideas. The management team has been occupied with the overall management and progress of the project; in particular, resources have been used to ensure advancements of all the activities related to WP 1 to 6. In addition, the management team have been engaged in analyses of existing and possible challenges that may impact the project, and with the identification and handling of activities related to dissemination and exploitation.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

The expected progress beyond the state of the art described in the initial project proposal defined the projects aim to provide patients, HCPs, the health care system and society with a novel disease management tool. In relation to these aims the project has currently delivered on the following aspects:
- In relation to the aim of advancing ICT elements to the users, the market, and society at large the device and software companies are well underway in ensuring approvals of the ICT platform and it´s respective elements
- With respect to the evaluation of user aspects the Consortium has completed multiple national evaluations via a novel combination of participatory design and stakeholder evaluation process´. This has been related to the ICT platform and its elements, and the work will continue in the project via focusing on feasibility testing of the concept and the platform
- Concerning the documentation of the projects impact the Consortium has completed initial testing (described above), engaged and completed discussions regarding health economy, reimbursement, and organisational impact on national levels, and commenced interactions with the political level
- As explained above the Consortium is well underway with regard to putting eHealth into practice. In addition, the Consortium is continuously working on the dissemination and exploitation of ELECTORs clinical concept and the elements of the projects ICT platform, both with respect to business development and the initiation of subsequent projects

Related information

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top